Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Leukemia
Related studies linked through entity extraction aliases.
Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE1
Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
- Status
- COMPLETED
- Phase
- PHASE2
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients
- Status
- UNKNOWN
- Phase
- N/A
Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
- Status
- COMPLETED
- Phase
- NA
Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies.
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk
- Status
- COMPLETED
- Phase
- PHASE2
E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1